(Q73715471)
Statements
Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma (English)
B A Pulaski
V K Clements
M R Pipeling
S Ostrand-Rosenberg